CODX vs LCID · rev $3.9M vs rev $1.35B
Co-Diagnostics, Inc. Common Stock (CODX) versus Lucid Group Inc (LCID) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Lucid Group Inc (LCID) is a auto manufacturers company listed on NASDAQ. It is led by Peter Rawlinson.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported LCID revenue for 2025-12-31 was $1.35B. Net income was -$2.70B. Revenue was up 67.6% from 2024-12-31 to 2025-12-31. LCID currently screens at market cap $2.04B.
CODX currently screens at market cap $31.4M. LCID currently screens at market cap $2.04B.
Not investment advice. Open the CODX and LCID stock pages for the full models.
Not investment advice.